Vistra announces strategic acquisition of iiPay to create a top 4 market leader in global multi-country payroll
HONG KONG, May 7, 2025 /PRNewswire/ -- Vistra, a leading provider of essential business services that help organizations to invest, grow and operate efficiently and compliantly across the world, today announced it has entered into an agreement to...
Rockefeller Foundation Announces Latest Steps to Accelerate Community-Focused Energy Transition Projects during Ecosperity Week
Collaboration between ACEN Corporation, GenZero , Keppel, and Mitsubishi for pilot project in the Philippines Approval of a methodology by Verra that will accelerate the world's first transition credits Scaling up support for 60 plant transitions...
Flytxt announces strategic AI collaborations across key markets to drive co-innovation and value creation
DUBAI, UAE, May 7, 2025 /PRNewswire/ -- Flytxt, a pioneer in Agentic AI solutions for subscription businesses, today announced a major initiative to expand its market footprint through a series of strategic go-to-market partnerships, unveiled at the...
Lake Resources Announces Exploration of Strategic Alternatives
SYDNEY, May 7, 2025 /PRNewswire/ -- Lake Resources N.L. (ASX: LKE; OTC: LLKKF) ("Lake" or the "Company"), a responsible lithium developer, announced today that its Board of Directors will form a Special Committee composed of all members of the Board...
Bispecific vs. Bispecific: Innovent Announces First Patient Dosed in the Phase 2 Clinical Study of Efdamrofusp Alfa (IBI302), a First-in-class Anti-VEGF and Anti-Complement Bispecific Fusion Protein for the Treatment of Diabetic Macular Edema
SAN FRANCISCO and SUZHOU, China, May 7, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of...
Everest Medicines Announces NMPA Full Approval of NEFECON® for the Treatment of Primary Immunoglobulin A nephropathy (IgAN) in Adults at Risk of Disease Progression
SHANGHAI, May 7, 2025 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialization of innovative therapeutics, today...
Formosa Pharmaceuticals Announces Licensing Agreement with Apotex Inc., for Commercialization of Clobetasol Propionate Ophthalmic Suspension for Post-Ocular Surgery Inflammation and Pain for Mexico
TAIPEI, May 7, 2025 /PRNewswire/ -- Taiwan-based Formosa Pharmaceuticals ("Formosa", 6838.TW) announced today that the company has entered into an exclusive licensing agreement with Apotex Inc. ("Apotex"), for exclusive rights in Mexico for the...
XChange TEC.INC Announces Plan to Implement ADS Ratio Change
SHANGHAI, May 7, 2025 /PRNewswire/ -- XChange TEC.INC (NASDAQ: XHG) (the "Company") today announced that it plans to change the ratio of the American depositary shares ("ADSs") representing its Class A ordinary shares from one (1) ADS representing...
Golden Heaven Group Holdings Ltd. Announces 25 for 1 Share Consolidation
NANPING, China, May 7, 2025 /PRNewswire/ -- Golden Heaven Group Holdings Ltd. ("Golden Heaven" or the "Company") (Nasdaq: GDHG), an amusement park operator in China, today announced that the Company's board of directors approved on April 23, 2025...
Paradigm Therapeutics, Inc. Announces Investment by Eshelman Ventures, LLC to Support Completion of Development of SD-101 (Zorblisa™), A Topical Therapy for Treatment Across the Entire Skin Surface of All Subtypes of Epidermolysis Bullosa (EB)
First Topical Therapy Developed to Treat the Wounds and Lesions on the Entire Skin Surface Across All EB Subtypes Funding to be Used for Completion of All Activities to Support Planned NDA Submission in the Second Half of 2025, Along with Plans for...